{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:32:28Z","timestamp":1790127148710,"version":"4.0.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009705","name":"Council for Chemical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012100","name":"Associazione Italiana Contro le Leucemie-Linfomi e Mieloma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHE 2120\/1-1"],"award-info":[{"award-number":["SCHE 2120\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000174","name":"Division of Antarctic Infrastructure and Logistics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ccell.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T10:36:12Z","timestamp":1714646172000},"page":"833-849.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas"],"prefix":"10.1016","volume":"42","author":[{"given":"Jaewoo","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"H\u00e4upl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Scheich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagan","family":"Muppidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio G.","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2024.04.007_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/1097-0142(194911)2:6<943::AID-CNCR2820020602>3.0.CO;2-P","article-title":"Adrenocorticotropic hormone- and cortisone-induced regression of lymphoid tumors in man; a preliminary report","volume":"2","author":"Pearson","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2024.04.007_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood.V6.9.804.804","article-title":"The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma","volume":"6","author":"Rosenthal","year":"1951","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(83)90171-X","article-title":"Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region","volume":"35","author":"Payvar","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/304749a0","article-title":"The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus","volume":"304","author":"Scheidereit","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2024.04.007_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molcel.2011.06.016","article-title":"Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding","volume":"43","author":"Biddie","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib9","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib10","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib15","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib17","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib20","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib21","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/2159-8290.CD-22-1401","article-title":"Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas","volume":"13","author":"Scheich","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2024.04.007_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2016-10-747303","article-title":"Tonic B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"130","author":"Havranek","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib27","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/leu.2008.163","article-title":"Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib","volume":"22","author":"Yang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.04.007_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ni893","article-title":"Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development","volume":"4","author":"Saijo","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.20.081501.130710","article-title":"Negative regulation of immunoreceptor signaling","volume":"20","author":"Veillette","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib30","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0064","article-title":"Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/jm050754u","article-title":"Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in\u00a0vitro and in\u00a0vivo","volume":"49","author":"Wendt","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib33","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1128\/MCB.22.24.8539-8551.2002","article-title":"Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter","volume":"22","author":"Sigvardsson","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2024.04.007_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1101\/gad.309583.117","article-title":"Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming","volume":"32","author":"Li","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2024.04.007_bib35","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/emboj\/17.8.2319","article-title":"Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments","volume":"17","author":"Nutt","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2024.04.007_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.molcel.2011.04.011","article-title":"Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication","volume":"42","author":"Ren","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5003","article-title":"Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation","volume":"6","author":"Calder\u00f3n","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20152002","article-title":"Molecular functions of the transcription factors E2A and E2-2 in controlling germinal center B cell and plasma cell development","volume":"213","author":"W\u00f6hner","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib39","first-page":"7306","article-title":"Functional analysis of Csk in signal transduction through the B-cell antigen receptor","volume":"14","author":"Hata","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2024.04.007_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4049\/jimmunol.1000371","article-title":"A role for lysosomal-associated protein transmembrane 5 in the negative regulation of surface B cell receptor levels and B cell activation","volume":"185","author":"Ouchida","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12792","article-title":"Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment","volume":"291","author":"Young","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2024.04.007_bib42","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2024.04.007_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00373.x","article-title":"A library of gene expression signatures to illuminate normal and pathological lymphoid biology","volume":"210","author":"Shaffer","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2024.04.007_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21856","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","volume":"6","author":"Skene","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2024.04.007_bib45","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1101\/gr.097022.109","article-title":"Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation","volume":"19","author":"Reddy","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2024.04.007_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2002-02-0538","article-title":"Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10","volume":"101","author":"Berrebi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.04.007_bib48","doi-asserted-by":"crossref","first-page":"23861","DOI":"10.1074\/jbc.M301843200","article-title":"Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis","volume":"278","author":"Wang","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1541-7786.MCR-13-0625","article-title":"REDD1\/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes","volume":"12","author":"Wolff","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2024.04.007_bib50","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.1921187117","article-title":"Regulation of B cell receptor-dependent NF-kappaB signaling by the tumor suppressor KLHL14","volume":"117","author":"Choi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109673","article-title":"The adaptor protein APS modulates BCR signalling in mature B cells","volume":"73","author":"Dondi","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ccell.2024.04.007_bib52","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.0904176","article-title":"Bam32\/DAPP1 promotes B cell adhesion and formation of polarized conjugates with T\u00a0cells","volume":"184","author":"Al-Alwan","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib53","first-page":"2973","article-title":"AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.04.007_bib54","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/eji.201242371","article-title":"Interaction of TAPP adapter proteins with phosphatidylinositol (3,4)-bisphosphate regulates B-cell activation and autoantibody production","volume":"42","author":"Landego","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10786","article-title":"Non-canonical antagonism of PI3K by the kinase Itpkb delays thymocyte beta-selection and renders it Notch-dependent","volume":"5","author":"Westernberg","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2024.04.007_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1101\/gad.14.5.505","article-title":"Structure, function, and biology of SHIP proteins","volume":"14","author":"Rohrschneider","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2024.04.007_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molcel.2004.10.028","article-title":"The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA","volume":"16","author":"Cartron","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/338383b0","article-title":"Antigen receptor tail clue","volume":"338","author":"Reth","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1097-2765(02)00739-6","article-title":"Amplification of B cell antigen receptor signaling by a Syk\/ITAM positive feedback loop","volume":"10","author":"Rolli","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib60","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/humu.23008","article-title":"Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance","volume":"37","author":"Vitellius","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ccell.2024.04.007_bib61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1084\/jem.20180595","article-title":"Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses","volume":"216","author":"Franco","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.04.007_bib62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2022015926","article-title":"Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma","volume":"140","author":"Pindzola","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib63","article-title":"Design and use of analog-sensitive protein kinases","volume":"Chapter 18","author":"Blethrow","year":"2004","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ccell.2024.04.007_bib64","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/acsmedchemlett.9b00354","article-title":"Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase","volume":"10","author":"O'Malley","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ccell.2024.04.007_bib65","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1074\/jbc.273.15.8867","article-title":"Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases","volume":"273","author":"Deckert","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib66","doi-asserted-by":"crossref","first-page":"8768","DOI":"10.1074\/jbc.M609920200","article-title":"Activation mechanism and steady state kinetics of Bruton's tyrosine kinase","volume":"282","author":"Dinh","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","article-title":"The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity","volume":"13","author":"Fearon","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.04.007_bib68","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1074-7613(00)00079-0","article-title":"BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation","volume":"13","author":"Okada","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.04.007_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108957118","article-title":"Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway","volume":"118","author":"Lu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2007.03.015","article-title":"Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b","volume":"26","author":"Kitaura","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.04.007_bib71","doi-asserted-by":"crossref","first-page":"43646","DOI":"10.1074\/jbc.M404082200","article-title":"Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl","volume":"279","author":"Shao","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib72","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M404114200","article-title":"Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations","volume":"279","author":"Kassenbrock","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib73","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/j.1460-2075.1991.tb04905.x","article-title":"A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation","volume":"10","author":"Hagman","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2024.04.007_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib75","doi-asserted-by":"crossref","first-page":"30487","DOI":"10.1074\/jbc.271.48.30487","article-title":"CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells","volume":"271","author":"Yanagi","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2024.04.007_bib76","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.immuni.2016.10.013","article-title":"Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells","volume":"45","author":"Skrzypczynska","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.04.007_bib77","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2011.10.011","article-title":"Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy","volume":"35","author":"O'Neill","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.04.007_bib78","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4161\/cc.4.11.2139","article-title":"Growth control under stress: mTOR regulation through the REDD1-TSC pathway","volume":"4","author":"Ellisen","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ccell.2024.04.007_bib79","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.2005.025858","article-title":"Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas","volume":"59","author":"Okazaki","year":"2006","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.ccell.2024.04.007_bib80","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41586-022-04906-8","article-title":"Super-enhancer hypermutation alters oncogene expression in B cell lymphoma","volume":"607","author":"Bal","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08088","article-title":"Small molecule inhibition of Csk alters affinity recognition by T\u00a0cells","volume":"4","author":"Manz","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2024.04.007_bib82","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1101\/gad.897601","article-title":"BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak","volume":"15","author":"Zong","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2024.04.007_bib83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib84","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.278.5338.687","article-title":"Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt","volume":"278","author":"del Peso","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.04.007_bib85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib86","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.2018891598","article-title":"Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed\/refractory non-germinal center B-cell-like DLBCL","volume":"134","author":"Goy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib87","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1200\/JCO.2019.37.15_suppl.7508","article-title":"Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma","volume":"37","author":"Westin","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.04.007_bib88","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00277-021-04535-7","article-title":"Ibrutinib combined with venetoclax for the treatment of relapsed\/refractory diffuse large B cell lymphoma","volume":"100","author":"Zhou","year":"2021","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ccell.2024.04.007_bib89","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1535-7163.MCT-16-0555","article-title":"Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma","volume":"16","author":"Kuo","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2024.04.007_bib90","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2023-180173","article-title":"Phase Ib\/II study of multi-targeted therapy with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed\/refractory (R\/R) diffuse large-B-cell lymphoma (DLBCL)","volume":"142","author":"Melani","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.04.007_bib92","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.05171-11","article-title":"Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu","volume":"85","author":"Janaka","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ccell.2024.04.007_bib93","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1128\/JVI.77.22.12011-12021.2003","article-title":"G541R within the 4070A TM protein regulates fusion in murine leukemia viruses","volume":"77","author":"O'Reilly","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ccell.2024.04.007_bib94","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2024.04.007_bib95","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2024.04.007_bib96","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib97","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.04.007_bib98","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","article-title":"Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma","volume":"9","author":"Arthur","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.04.007_bib99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.04.007_bib100","doi-asserted-by":"crossref","first-page":"99237","DOI":"10.18632\/oncotarget.18502","article-title":"Comparative analysis of primary versus relapse\/refractory DLBCL identifies shifts in mutation spectrum","volume":"8","author":"Greenawalt","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2024.04.007_bib101","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/gcc.22328","article-title":"Whole exome sequencing of relapsed\/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma","volume":"55","author":"Mareschal","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ccell.2024.04.007_bib102","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib103","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.04.007_bib104","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.2020007683","article-title":"Characterization of DLBCL with a PMBL gene expression signature","volume":"138","author":"Duns","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.04.007_bib105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40164-022-00325-7","article-title":"Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma","volume":"11","author":"Li","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.ccell.2024.04.007_bib106","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2024.04.007_bib107","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.04.007_bib108","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkp335","article-title":"MEME SUITE: tools for motif discovery and searching","volume":"37","author":"Bailey","year":"2009","journal-title":"Nucleic Acids Res."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:33:08Z","timestamp":1773235988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610824001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1535610824001314"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2024.04.007","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}